Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
That is all the official record says: Geno LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
No investor of Geno LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 41 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
People named by Geno LLC
Name
Role
Named in
Brent V. Furse
Executive officer
Dec 2021
Roberto V. Cohen
Executive officer
Dec 2021
Shasha V. Zou
Executive officer
Dec 2021
Anthony Scott Loumidis
Executive officer
Sep 2017
Brent H. Furse
Executive officer
Sep 2017
David H. Fine, Ph.D.
Executive officer
Sep 2017
Paul Scott Antinori
Executive officer
Sep 2017
Tod Scott Shultz
Executive officer
Sep 2017
Anthony Loumidis
Chief Financial Officer.
Oct 2013
David Fine
Executive Chairman, Chief Scientific Officer and Managing Member of the LLC.
Oct 2013
Kurt Dasse
Chief Executive Officer, President and a Managing Member of the LLC.
Oct 2013
Robert Roscigno
Executive Vice President.
Oct 2013
James O'Brien
James O'Brien is a Manager
Sep 2009
Steven Shulman
Steven Shulman is a Manager
Sep 2009
Brent V. Furse
Director
Dec 2021
Daniel Salazar
Director
Dec 2021
Eric V. Bednarski
Director
Dec 2021
Thiago V. Tavares
Director
Dec 2021
Todd Brady
Director
Dec 2021
Brent H. Furse
Director
Sep 2017
Dan Scott Salazar, Ph.D.
Director
Sep 2017
David H. Fine, Ph.D.
Director
Sep 2017
T. Scott Johnson, M.D.
Director
Sep 2017
Theo Scott Melas-Kyriazi
Director
Sep 2017
Todd Scott Brady
Director
Sep 2017
Vinzenz Scott Ploerer
Director
Sep 2017
David Fine
Executive Chairman, Chief Scientific Officer and Managing Member of the LLC.
Oct 2013
Kurt Dasse
Chief Executive Officer, President and a Managing Member of the LLC.